Republican and Democratic senators agreed at a recent Senate Judiciary Committee hearing to focus on patent reform to stop pharmaceutical firms from extending their product patents, which drives high prescription drug prices. Experts who attended the hearing said improving coordination between the FDA and the US Patent and Trademark Office on patents listed on the Orange Book could help address the issue.

Full story: https://www.raps.org/news-and-articles/news-articles/2024/5/experts,-lawmakers-express-support-for-select-drug